about
Pathophysiological links between traumatic brain injury and post-traumatic headachesSpotlight on frovatriptan: a review of its efficacy in the treatment of migraineEfficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.Education and decision making at the time of triptan prescribing: patient expectations vs actual practice.Anti-CGRP monoclonal antibodies in migraine: current perspectives.Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.Why pharmacokinetic differences among oral triptans have little clinical importance: a comment.Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraineAdverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: systematic review of observational studies.Calcitonin gene-related peptide (CGRP): a new target for migraineEfficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.Efficacy of frovatriptan versus other triptans in the acute treatment of menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian studyFrovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative studyModulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist.Symptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy.A review of the use of frovatriptan in the treatment of menstrually related migraine.Frovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.Human factors validation study of 3 mg sumatriptan autoinjector, for migraine patients.CGRP and migraine: could PACAP play a role too?Frovatriptan and rizatriptan economic EVAluation: the FREEVA study.Induction of Migraine-Like Photophobic Behavior in Mice by Both Peripheral and Central CGRP Mechanisms.Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs.Gene polymorphisms involved in triptans pharmacokinetics and pharmacodynamics in migraine therapy.Frovatriptan versus other triptans in the acute treatment of migraine: pooled analysis of three double-blind, randomized, cross-over, multicenter, Italian studies.Chemical mediators of migraine: preclinical and clinical observations.Pharmacokinetic evaluation of frovatriptan.Needle-free subcutaneous sumatriptan: in the acute treatment of migraine attacks or cluster headache episodes.Frovatriptan: a review of its use in the acute treatment of migraine.Cost-effectiveness of oral triptans for acute migraine: mixed treatment comparison.Acute treatment of migraine: established and emerging therapies.Abdominal migraine in adults: a review of pharmacotherapeutic options.Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.Biomarkers associated with migraine and their potential role in migraine management.Sumatriptan-associated ischemic colitis: case report and review of the literature and FAERS.The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.Blood gene expression studies in migraine: Potential and caveats.Chronic migraine treatment: from OnabotulinumtoxinA onwards.Butalbital and pediatric headache: stay off the downward path.
P2860
Q28067288-E92C0974-9994-4147-B138-BDD3D8C54F6EQ28078673-FE17D58D-9BDD-4C3F-B23B-472112732F28Q33958060-D1F1993E-1D0C-458D-9B49-D2E9EF7F11CFQ34472169-0BE4B67F-8799-4B86-9B82-6698BE2DA167Q34531880-E6BCB57D-BCC9-4783-A7C9-F75B13157F54Q34558284-975ED1A7-B96A-4D17-B7A1-9769FE4D4030Q34770884-510A90C6-4840-4FD9-B930-D41D8AFD240FQ34890784-4541C1B3-D9B4-4FE4-ACF8-661EA9046E9CQ34981791-6FA30970-1480-4B84-B72C-47D74A29BD0EQ35270090-148A245D-4891-48C8-A1ED-7E7AAE273958Q35358428-2C497B0E-EB2F-4311-934B-B3A88723489EQ35522772-E3BB4CB0-57B5-4E80-A603-EAE2C28FDC25Q35996147-C3C53BC9-CC85-4817-B8EC-373D9D89BA74Q35996223-03A6FB2B-A799-49BC-94BA-66190EB2B6F4Q36052155-7416071B-83B2-42A1-9486-EA63CFBAF681Q36401525-8BB5B032-E3F1-4B1F-8AA6-4EB42C936368Q36554913-5B68604F-4C08-412D-A9F7-A3875D2A7AE8Q36638660-482A56D8-ED06-4AF4-B491-6FAE879226A0Q36865920-5A75F419-A3E1-424D-9933-7C8CB8FA97B7Q36967962-1746BD3E-9D83-40A8-AA94-300E8618B50DQ37384128-FB8807EE-15F9-4F62-B572-FB0AD42E9832Q37427358-EB809740-F4B8-49A6-BC68-7C64DCE91EABQ37558868-C4DC08F3-CDE1-44A6-AAA3-FFC0AF9EAF54Q37603685-BAF037A6-89B0-49E0-A605-877346825CE4Q37818258-C9E8ADED-A9FF-4C8C-84A4-EA3316402FFBQ37870791-E8B2A6BF-E8BC-456C-B104-ED963F4D93A7Q37883455-6D424CDD-0280-4E56-8524-25DDD9F22AD7Q37935031-C6F2EEC4-092F-4BB7-9222-6209A58EF705Q37952825-90F2EB93-5467-4CBA-B4EF-4BEB4D121766Q38035403-B5CD6F77-4A3C-4391-A983-052793412AE8Q38046676-8A998515-D7A6-4D4A-89B3-E2FE54059A4AQ38048893-4A0F85EF-AC8F-4FA7-84A1-6BD2C6496FC7Q38106837-EC59E1C5-9C8E-491C-9491-F7CFACFF6432Q38108485-8A3BF7AA-59ED-4D83-B140-EA2A92E89F65Q38121110-6A722A41-0008-4CC9-A5CF-8804F308E907Q38180026-A7681678-3177-40A2-82B6-67ABA2986265Q38563244-E5C158BE-96C5-4588-B018-579913140775Q38728036-9EF74E9A-D206-4215-9AE0-B63CBA06768EQ38866988-C4EEC038-7AAD-471A-AE79-5BF8B23DC2E1Q39196833-7E8D0496-DFBB-4BE9-80F2-ADFC57D46504
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Triptan therapy in migraine.
@en
Triptan therapy in migraine.
@nl
type
label
Triptan therapy in migraine.
@en
Triptan therapy in migraine.
@nl
prefLabel
Triptan therapy in migraine.
@en
Triptan therapy in migraine.
@nl
P356
P1476
Triptan therapy in migraine.
@en
P2093
Elizabeth Loder
P356
10.1056/NEJMCT0910887
P407
P577
2010-07-01T00:00:00Z